Abstract
Here we identify approximately 40,000 healthy human volunteers who were intentionally exposed to infectious pathogens in clinical research studies dating from late World War II to the early 2000s. Microbial challenge experiments continue today under contemporary human subject research requirements. In fact, we estimated 4,000 additional volunteers who were experimentally infected between 2010 and the present day. We examine the risks and benefits of these experiments and present areas for improvement in protections of participants with respect to safety. These are the absence of maximum limits to risk and the potential for institutional review boards to include questionable benefits to subjects and society when weighing the risks and benefits of research protocols. The lack of a duty of medical care by physician–investigators to research subjects is likewise of concern. The transparency of microbial challenge experiments and the safety concerns raised in this work may stimulate further dialogue on the risks to participants of human experimentation.
Similar content being viewed by others
Notes
US Select Agents are defined in Title 7 Code of Federal Regulations part 331 (7CFR331), 9CFR121, and 42CFR73; the ‘Select Agent and toxins regulations’.
The ‘HHS regulations’ are administered under the HHS Assistant Secretary for Health by the Office for Human Research Protections (OHRP) under 45CFR46, part A of which constitutes the US federal Common Rule. The FDA is an agency division of the HHS and ‘FDA regulations’ refers to the clinical research regulations codified in 21CFR50, 21CFR56, 21CFR312 and 21CFR812. The CDC, NIH and FDA are divisions of the PHS but OHRP is not.
References
Abbott, L., & Grady, C. (2011). A systematic review of the empirical literature evaluating IRBs: What we know and what we still need to learn. Journal of Empirical Research on Human Research Ethics, 6, 3–19.
Academy of Medical Sciences. (2005). Microbial challenge studies of human volunteers. http://www.acmedsci.ac.uk/viewFile/publicationDownloads/1127728424.pdf. Accessed 16 March 2014.
Annas, G. J. (1991). Mengele’s birthmark: The Nuremberg Code in United States courts. Journal of Contemporary Health Law and Policy, 7(1), 7–45.
Beecher, H. K. (1959). Experimentation in man. Journal of the American Medical Association, 169, 461–478.
Benson, W. W., Brock, D. W., & Mather, J. (1963). Serologic analysis of a penitentiary group using raw milk from a Q fever infected herd. Public Health Reports, 78, 707–710.
Black, R. E., Levine, M. M., Clements, M. L., Hughes, T. P., & Blaser, M. J. (1988). Experimental Campylobacter jejuni infection in humans. Journal of Infectious Diseases, 157, 472–479.
Bramstedt, K. A., & Kassimatis, K. (2004). A study of warning letters issued to institutional review boards by the United States Food and Drug Administration. Clinical and Investigative Medicine, 27(6), 316–323.
Carrat, F., Vergu, E., Ferguson, N. M., Lemaitre, M., Cauchemez, S., Leach, S., et al. (2008). Time lines of infection and disease in human influenza: a review of volunteer challenge studies. American Journal of Epidemiology, 167, 775–785.
Centers for Disease Control and Prevention. (2014). Key facts about seasonal flu vaccine. http://www.cdc.gov/flu/protect/keyfacts.htm. Accessed 27 June 2014.
Chaves-Carballo, E. (2013). Clara Maass, yellow fever and human experimentation. Military Medicine, 178(5), 557–562.
Council for International Organizations of Medical Sciences. (2002). International ethical guidelines for biomedical research involving human subjects. http://www.cioms.ch/publications/guidelines/guidelines_nov_2002_blurb.htm. Accessed 27 June 2014.
Council of Europe. (2005). Additional Protocol to the Convention on Human Rights and Biomedicine, concerning biomedical research. http://conventions.coe.int/Treaty/en/Treaties/Html/195.htm. Accessed 27 June 2014.
Council of Europe Steering Committee on Bioethics. (2012). Guide for research ethics committee members. http://www.coe.int/t/dg3/healthbioethic/activities/02_biomedical_research_en/guide/Guide_EN.pdf. Accessed 10 June 2014.
Edwards, S. J. L., Kirchin, S., & Huxtable, R. (2004). Research ethics committees and paternalism. Journal of Medical Ethics, 30, 88–91.
Emanuel, E., Wendler, D., & Grady, C. (2000). What makes clinical research ethical? Journal of the American Medical Association, 283(20), 2701–2711.
Epstein, J. E. (2013). Taking a bite out of malaria: Controlled human malaria infection by needle and syringe. American Journal of Tropical Medicine and Hygiene, 88, 3–4.
Food and Drug Administration. (2010). Payment to research subjects information sheet, guidance for institutional review boards and clinical investigators. http://www.fda.gov/regulatoryinformation/guidances/ucm126429.htm. Accessed 16 March 2014.
Frieden, T. R., & Collins, F. J. (2010). Intentional infection of vulnerable populations in 1946–1948: another tragic history lesson. Journal of the American Medical Association, 304(18), 2063–2064.
Friedman, M. & Friedman, R. D. (1990) Free to choose: A personal statement. Harcourt Inc.
Gogtay, N. J., Doshi, B. M., Kannan, S., & Thatte, U. (2011). A study of warning letters issued to clinical investigators and institutional review boards by the United States Food and Drug Administration. Indian Journal of Medical Ethics, 8(4), 211–214.
Goldenberg, L. R., Owens, E. F, Jr, & Pickar, J. G. (2007). Recruitment of research volunteers: methods, interest, and incentives. Journal of Chiropractic Education, 21(1), 28–31.
Henle, W., & Henle, G. (1946). Experimental exposure of human subjects to viruses of influenza. Journal of Immunology, 52, 145–165.
Hobbs, M. M., Sparling, P. F., Cohen, M. S., Shafer, W. M., Deal, C. D., & Jerse, A. E. (2011) Experimental gonococcal infection in male volunteers: Cumulative experience with neisseria gonorrhoeae strains FA1090 and MS11mkC. Frontiers in Microbiology, 2. doi:10.3389/fmicb.2011.00123.
International Conference on Harmonization of technical requirements for registration of pharmaceuticals for human use. (1996). Guideline for good clinical practice E6(R1). http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R1/Step4/E6_R1__Guideline.pdf. Accessed 27 June 2014.
Janowicz, D. M., Ofner, S., Katz, B. P., & Spinola, S. M. (2009). Experimental infection of human volunteers with Haemophilus ducreyi: Fifteen years of clinical data and experience. Journal of Infectious Diseases, 199, 1671–1679.
Jansson, R. L. (2003). Researcher liability for negligence in human subject research: Informed consent and researcher malpractice actions. Washington Law Review, 78, 229–263.
Joffe, S., & Miller, F. G. (2008). Bench to bedside: mapping the moral terrain of clinical research. Hastings Center Report, 38(2), 30–42.
Kalil, J. A., Halperin, S. A., & Langley, J. M. (2012). Human challenge studies: A review of adequacy of reporting methods and results. Future Microbiology, 7, 481–495.
Katz, D. E., Coster, T. S., Wolf, M. K., Trespalacios, F. C., Cohen, D., Robins, G., et al. (2004). Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers. Infection and Immunity, 72(2), 923–930.
Kirkpatrick, B. D., Lyon, C. E., Porter, C. K., Maue, A. C., Guerry, P., Pierce, K. K., et al. (2013). Lack of homologous protection against Campylobacter jejuni CG8421 in a human challenge model. Clinical Infectious Diseases, 57, 1106–1113.
Knight, V. (1964). The use of volunteers in medical virology. Progress in Medical Virology, 6, 1–26.
Kotloff, K. L. (2003). Human challenge studies with infectious agents. Journal of Investigative Medicine, 51(supp. 1), S6–S11.
Krugman, S. (1986). The Willowbrook hepatitis studies revisited: ethical aspects. Reviews of Infectious Diseases, 8, 157–162.
Lemmons, T., & Elliott, C. (2001). Justice for the professional guinea pig. American Journal of Bioethics, 1(2), 51–53.
Levine, M. M., Tacket, C. O., & Sztein, M. B. (2001). Host-Salmonella interaction: Human trials. Microbes and Infection, 3, 1271–1279.
Lie, R. K., Emanuel, E., Grady, C., & Wendler, D. (2004). The standard of care debate: The Declaration of Helsinki versus the international consensus opinion. Journal of Medical Ethics, 30, 190–193.
London, A. J. (2006). Reasonable risks in clinical research: a critique and a proposal for the Integrative Approach. Statistics in Medicine, 25(17), 2869–2885.
Lynch, H. F. (2012). The rights and wrongs of intentional exposure research: Contextualizing the Guatemala STD inoculation study. Journal of Medical Ethics, 38, 513–515.
MacCallum, F. O. (1946). Homologous serum hepatitis. Proceedings of the Royal Society of Medicine, 39, 655–657.
Macklin, R. (1989). The paradoxical case of payment as benefit to research subjects. IRB, 11(6), 1–3.
Mastroianni, A. C., & Kahn, J. P. (2002). Risk and responsibility: Ethics, Grimes v Kennedy Krieger, and public health research involving children. American Journal of Public Health, 92, 1073–1076.
Miller, F. G., & Grady, C. (2001). The ethical challenge of infection-inducing challenge experiments. Clinical Infectious Diseases, 33, 1028–1033.
Miller, F. G., & Joffe, S. (2009). Limits to research risks. Journal of Medical Ethics, 35(7), 445–449.
Office for Human Subjects Research Protection. (1993). Institutional review board guidebook. http://www.hhs.gov/ohrp/archive/irb/irb_guidebook.htm. Accessed 26 March 2014.
Oxford, J. S. (2013). Towards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensing. British Journal of Clinical Pharmacology, 76, 210–216.
Oxford, J. S., Gelder, C., & Lambkin, R. (2005). Would you volunteer to be quarantined and infected with influenza virus? Expert Review of Anti-Infective Therapy, 3(1), 1–2.
Pittman, P. R., Norris, S. L., Coonan, K. M., & McKee, K. T, Jr. (2005). An assessment of health status among medical research volunteers who served in the Project Whitecoat program at Fort Detrick, Maryland. Military Medicine, 170, 183–187.
Pollard, A. J., Savulescu, J., Oxford, J., Hill, A. V., Levine, M. M., Lewis, D. J., et al. (2012). Human microbial challenge: The ultimate animal model. The Lancet Infectious Diseases, 12, 903–905.
Porter, C. K., Riddle, M. S., Tribble, D. R., Louis Bougeois, A., McKenzie, R., Isidean, S. D., et al. (2011). A systematic review of experimental infections with enterotoxigenic Escherichia coli (ETEC). Vaccine, 29, 5869–5885.
Presidential Commission for the Study of Bioethical Issues. (2011). “Ethically impossible” STD research in Guatemala from 1946 to 1948. http://bioethics.gov/sites/default/files/Ethically-Impossible_PCSBI.pdf. Accessed 26 March 2014.
Preston Church, L. W., Le, T. P., Bryan, J. P., Gordon, D. M., Edelman, R., Fries, L., et al. (1997). Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. Journal of Infectious Diseases, 175, 915–920.
Reed, W. (1902). Recent Researches Concerning the Etiology, Propagation, and Prevention of Yellow Fever, by the United States Army Commission. Journal of Hygiene (London), 2, 101–119.
Resnik, D. B. (2012). Limits on risks for healthy volunteers in biomedical research. Theoretical Medicine and Bioethics, 33(2), 137–149.
Richardson, H. S., & Belsky, L. (2004). The ancillary-care responsibilities of medical researchers: an ethical framework for thinking about the clinical care that researchers owe their subjects. Hastings Center Report, 34(1), 25–33.
Rid, A., Emanuel, E. J., & Wendler, D. (2010). Evaluating the risks of clinical research. Journal of the American Medical Association, 304(13), 1472–1479.
Roxburgh, H. L. (1963). Experiments on human subjects. Medicine Science and the Law, 3, 132–140.
Shaw, D. (2014). The right to participate in high-risk research. Lancet, 383(9921), 1009–1011.
Shuster, E. (1997). Fifty years later: The significance of the Nuremberg Code. New England Journal of Medicine, 337(20), 1436–1440.
Thomas, S. J. (2013). Dengue human infection model: Re-establishing a tool for understanding dengue immunology and advancing vaccine development. Human Vaccines and Immunobeneficials, 9, 1587–1590.
Tyrrell, D. A. (1992). A view from the Common Cold Unit. Antiviral Research, 18, 105–125.
United Nations. (1948). The universal declaration of human rights. http://www.un.org/en/documents/udhr/. Accessed 27 June 2014.
von Hayek, F. A. (2007) In B. Caldwell (Ed.), The road to serfdom. London: University of Chicago Press.
Weijer, C. (2000). Ethical analysis of risk. Journal of Law Medicine and Ethics, 28, 344–361.
Weijer, C., & Miller, P. B. (2004). When are research risks reasonable in relation to anticipated benefits? Nature Medicine, 10(6), 570–573.
Wendler, D., & Miller, F. G. (2007). Assessing research risks systematically: The net risks test. Journal of Medical Ethics, 33, 481–486.
World Medical Association. (2013). World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. Journal of the American Medical Association, 310(20), 2191–2194.
Zarin, D. A., Tse, T., & Menikoff, J. (2014). Federal human research oversight of clinical trials in the United States. Journal of the American Medical Association, 311(9), 960–961.
Conflict of interest
The authors are employees of the US government.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Evers, D.L., Fowler, C.B., Mason, J.T. et al. Deliberate Microbial Infection Research Reveals Limitations to Current Safety Protections of Healthy Human Subjects. Sci Eng Ethics 21, 1049–1064 (2015). https://doi.org/10.1007/s11948-014-9579-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11948-014-9579-z